Arcadia Biosciences, Inc. (RKDA)
USD 3.15
(-1.56%)
USD 3.15
(-1.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.33 Million | 9.95 Million | 6.78 Million | 8.03 Million | 1.16 Million | 1.46 Million |
| Cost of Revenue | 3.3 Million | 9.8 Million | 8.7 Million | 5.19 Million | 885 Thousand | 661 Thousand |
| Gross Profit | 2.03 Million | 154 Thousand | -1.92 Million | 2.83 Million | 284 Thousand | 803 Thousand |
| Operating Expenses | 15.96 Million | 19.55 Million | 26.82 Million | 24.42 Million | 20.66 Million | 17.67 Million |
| Selling, General and Administrative Expenses | 14.5 Million | 18.04 Million | 22.93 Million | 16.46 Million | 13.56 Million | 11.6 Million |
| Research and Development Expenses | 1.38 Million | 1.5 Million | 3.88 Million | 7.96 Million | 7.09 Million | 6.06 Million |
| Other Expenses | 73 Thousand | 33 Thousand | 10.11 Million | 105 Thousand | 466 Thousand | -3.6 Million |
| Cost and Expenses | 19.26 Million | 29.35 Million | 35.53 Million | 29.62 Million | 21.55 Million | 18.33 Million |
| Operating Income | -13.93 Million | -19.4 Million | -35.52 Million | -21.59 Million | -20.38 Million | -16.87 Million |
| Interest Expense | - | 289 Thousand | 20 Thousand | 47 Thousand | 5000.00 | - |
| Income Tax Expense | 8000.00 | 14 Thousand | 2000.00 | -124 Thousand | 2000.00 | 10 Thousand |
| Earnings before Tax | -13.15 Million | -15.59 Million | -16.13 Million | -6.15 Million | -28.87 Million | -13.47 Million |
| Net Income | -13.98 Million | -15.61 Million | -16.13 Million | -6.02 Million | -28.87 Million | -13.48 Million |
| Earnings Per Share Basic | -11.30 | -26.05 | -30.33 | -24.20 | -181.50 | -143.16 |
| Earnings Per Share Diluted | -11.30 | -26.05 | -30.33 | -24.20 | -181.50 | -143.16 |
| Weighted Average Shares Outstanding | 1.23 Million | 599.38 Thousand | 532.01 Thousand | 248.97 Thousand | 159.07 Thousand | 94.16 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.23 Million | 599.38 Thousand | 532.01 Thousand | 248.97 Thousand | 159.07 Thousand | 94.16 Thousand |
| Gross Margin | 0.38 | 0.02 | -0.28 | 0.35 | 0.24 | 0.55 |
| EBIT Margin | -2.62 | -2.28 | -2.71 | -2.59 | -17.48 | -15.63 |
| Profit Margin | -2.62 | -1.57 | -2.38 | -0.75 | -24.70 | -9.21 |
| EBITDA | -13.93 Million | -13.64 Million | -23.26 Million | -5.44 Million | -28.67 Million | -13.31 Million |
| Earnings Before Tax Margin | -2.62 | -1.95 | -5.24 | -2.69 | -17.43 | -11.52 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.3 Million | 1.25 Million | 1.17 Million | 5.33 Million | 1.59 Million | 1.38 Million |
| Cost of Revenue | 633 Thousand | 820 Thousand | 670 Thousand | 3.3 Million | 1.1 Million | 981 Thousand |
| Gross Profit | 673 Thousand | 435 Thousand | 500 Thousand | 2.03 Million | 495 Thousand | 408 Thousand |
| Operating Expenses | 2.69 Million | 3.46 Million | 3.75 Million | 15.89 Million | 3.74 Million | 4.2 Million |
| Selling, General and Administrative Expenses | 2.68 Million | 3.18 Million | 3.42 Million | - | 3.44 Million | 3.81 Million |
| Research and Development Expenses | 10 Thousand | 272 Thousand | 332 Thousand | - | 305 Thousand | 391 Thousand |
| Other Expenses | 150 Thousand | 3000.00 | 12 Thousand | -382 Thousand | 17 Thousand | -13 Thousand |
| Cost and Expenses | 3.32 Million | 4.28 Million | 4.42 Million | 19.19 Million | 4.85 Million | 5.18 Million |
| Operating Income | -2.02 Million | -3.02 Million | -3.25 Million | -13.86 Million | -3.24 Million | -3.79 Million |
| Interest Expense | - | - | -198 Thousand | - | - | - |
| Income Tax Expense | 789 Thousand | 184.72 Thousand | 7000.00 | 8000.00 | 83 Thousand | 1000.00 |
| Earnings before Tax | 1.85 Million | -2.42 Million | -2.61 Million | -13.15 Million | -2.48 Million | 819 Thousand |
| Net Income | 1.06 Million | -2.42 Million | -2.85 Million | -13.98 Million | -2.56 Million | 823 Thousand |
| Earnings Per Share Basic | 0.78 | -1.78 | -2.22 | - | -1.89 | 0.60 |
| Earnings Per Share Diluted | 0.78 | -1.78 | -2.22 | - | -1.89 | 0.60 |
| Weighted Average Shares Outstanding | 1.36 Million | 1.36 Million | 1.28 Million | 1.23 Million | 1.35 Million | 1.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.36 Million | 1.36 Million | 1.28 Million | 1.23 Million | 1.35 Million | 1.35 Million |
| Gross Margin | 0.52 | 0.35 | 0.43 | 0.38 | 0.31 | 0.29 |
| EBIT Margin | -1.53 | -2.23 | -2.59 | - | -2.03 | -5.87 |
| Profit Margin | 0.81 | -1.93 | -2.44 | -2.62 | -1.61 | 0.59 |
| EBITDA | -2 Million | -2.79 Million | -3.03 Million | - | -3.24 Million | -8.15 Million |
| Earnings Before Tax Margin | -1.55 | -2.41 | -2.78 | -2.60 | -2.03 | -2.73 |
CTRI
NSFMF
7287
8103
603105
QCAAF